ClinicalTrials.govpublic full text
ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study
acute coronary syndrome, stent, percutaneous coronary transluminal angioplasty, bleeding, antiplatelet agents, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 801778
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.